Bioventures Investors

Venture Capital Exempt reporting adviser

Legal name: Bioventures II Management Corporation

Westborough, MA Website

AUM

$302.6M
Private fund assets

Private funds

6
Venture Capital 6

Private fund assets

$302.6M
Gross asset value

Employees

—

Last Form D raise

Dec 2022
Most recent fund filing

From SEC Form ADV filing (filed Mar 26, 2026). View on SEC

People(6)

Owners and executive officers named on the firm's SEC Form ADV.

J
James Lousararian
Managing Director of Bioventures Investors IV Management LLC
Source: SEC Form ADV
J
Jeffrey Barnes
Managing Director of Bioventures Investors IV Management LLC
Source: SEC Form ADV
J
Jonathan Gertler
Managing Director of Bioventures Medtech Growth Capital Management LLC
Source: SEC Form ADV
M
Marc Goldberg
President, Director, Shareholder
Source: SEC Form ADV
P
Peter Feinstein
Managing Director of Bioventures Investors II, LLC
Source: SEC Form ADV
W
Walter Gilbert
Managing Director of Bioventures Investors II, LLC
Source: SEC Form ADV

Funds(6)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Bioventures Investors Medtech Growth Capital LPVenture Capital$206.9M$204.5M3Dec 2022Cold
Bioventures Investors IV Limited PartnershipVenture Capital$27.3M$30.1M47Sep 2016Cold
Bioventures Investors (offshore) IV Limited PartnershipVenture Capital$45.1M———
Bioventures Investors III Limited PartnershipVenture Capital$13.3M———
Bioventures Investors Limited Partnership IIVenture Capital$7.6M———
Bioventures Investors (offshore) III LPVenture Capital$2.6M———

Board seats

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.

Regulatory identifiers

CRD number
161520
SEC file number
802-74905

Sources